Shah, Md Nur Ahad https://orcid.org/0000-0001-6548-1501
Wilton-Clark, Harry
Haque, Farhia
Powell, Brooklynn
Sutanto, Laura Edellein
Maradiya, Radha https://orcid.org/0009-0003-5730-438X
Zhabyeyev, Pavel https://orcid.org/0000-0003-0652-3235
Roshmi, Rohini Roy https://orcid.org/0000-0001-6415-6862
Anwar, Saeed https://orcid.org/0000-0003-3688-5923
Aslesh, Tejal https://orcid.org/0000-0003-1759-6915
Lim, Kenji Rowel Q. https://orcid.org/0000-0002-5484-4183
Maruyama, Rika
Bigot, Anne https://orcid.org/0000-0003-0337-5425
Young, Courtney S.
Bittner, Scott
Spencer, Melissa J. https://orcid.org/0000-0001-7104-544X
Moulton, Hong M. https://orcid.org/0000-0002-8095-1513
Oudit, Gavin Y.
Yokota, Toshifumi https://orcid.org/0000-0001-7316-3546
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN 143251, PS 169193)
Heart and Stroke Foundation of Canada (G-20-0029382)
Jesse’s Journey, Women and Children’s Health Research Institute
Article History
Received: 2 April 2024
Accepted: 24 April 2025
First Online: 14 May 2025
Competing interests
: T.Y. and Rika M. are cofounders of OligomicsTx Inc., which aims to commercialize antisense technology. The rest of the authors declare no conflict of interest.